20 April 2023
Baker McKenzie advises Ariceum Therapeutics on Extension of Series A Financing to EUR 47.75 million
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julia Braun Lead | Baker McKenzie | Partner | Corporate/M&A | Munich |
| Erik Kuhn | Baker McKenzie | Associate | Corporate/M&A | Munich |
| Anna Dzik | Baker McKenzie | Associate | Corporate/M&A | Munich |
Stated terms
- Stated value
- EUR 47.8m (EUR 47.75 million)
- What the figure measures
- Total transaction value
- Client
- Ariceum TherapeuticsIssuer
- Counterparties
- Andera Partners (Investor)
Earlybird Venture Capital (Investor)
Pureos Bioventures (Investor)